Voyager Therapeutics Inc has a consensus price target of $16 based on the ratings of 12 analysts. The high is $30 issued by HC Wainwright & Co. on April 8, 2025.The low is $7 issued by Wedbush on ...

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company’s lead product candidate is VY7523, an anti-tau antibody ...

Review the current Voyager Therapeutics Inc (VYGR:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if VYGR is the best investment for you.

Voyager Therapeutics, Inc. (VYGR) CEO Andre Turenne on Q4 2019 Results - Earnings Call Transcript SA Transcripts Tue, Mar. 03, 2020 Voyager Therapeutics, Inc. (VYGR) CEO Andre Turenne on Q3 2019 ...

In the latest shutdown, the cosmic ray subsystem experiment on Voyager 1 and Voyager 2’s low-energy charged particle ...

The Ministry of Defence has awarded a £170 million contract to AirTanker Ltd for a major upgrade to the UK's Voyager tanker ...

NASA has explored the space beyond Earth and our solar system with spacecraft like Voyagers 1 and 2, and how we’ve discovered ...

Far past the familiar boundaries of our solar system, NASA's intrepid Voyager spacecraft are sending back mind-boggling data, ...

While most members of Captain Janeway's crew lamented being trapped in the Delta Quadrant, one character will have been ...

The Royal Air Force’s air transport hub was breached by activists belonging to Palestine Action, who sprayed paint inside the ...

LONDON—Protesters broke into the UK Royal Air Force’s (RAF) main air transport base and sprayed red paint on two of the ...

Voyager chronicled the journey of Captain Janeway and her crew from the Delta Quadrant, which was 70,000 light years away.